Clinical trial

Comparative Effectiveness of a Breath-operated Albuterol Inhaler in Asthma…

NCT00054964 · Teva Branded Pharmaceutical Products R&D, Inc., Industry · Completed

Key facts

NCT number NCT00054964
Title Comparative Effectiveness of a Breath-operated Albuterol Inhaler in Asthma Patients With Poor Inhaler Technique
Official title Comparison of Single-dose Efficacy of Albuterol-HFA-BOI and Albuterol-HFA-MDI in Asthmatics With Poor Inhaler Coordinating Ability
Lead sponsor Teva Branded Pharmaceutical Products R&D, Inc., Industry
Status Completed
Phase Phase 2
Study type Interventional
Conditions Asthma
Intervention type Drug
Interventions Albuterol HFA-BOI, Albuterol HFA-MDI
Enrollment 14
Start date Mar 31, 2003
Primary completion Aug 31, 2003
Completion Aug 31, 2003
First posted Feb 17, 2003
Last update posted Nov 30, 2021
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies